報告題目：Design and selection of glycosidase inhibitors towards therapies for Diabetes and Influenza

報  告 人：Stephen G. Withers

加拿大不列顛哥倫比亞大學Khorana講席教授

英國皇家學會院士

加拿大皇家學會院士

UBC高通量生物學中心主任

報告時間：5月9日(星期五)上午10:00-11:30

報告地點：閔行校區生物藥學樓2-116

聯  系 人🏢：楊廣宇   021-34207248

報告摘要：

Carbohydrates play important roles in biological systems, not only in the form of energy storage materials such as starch, but also as “recognition elements” on cell surfaces. The synthesis and degradation of such sugar structures is achieved using enzymes known as glycosyl transferases and glycoside hydrolases (glycosidases) respectively. Specific enzyme inhibitors are not only useful tools for understanding enzyme mechanisms, but also can play important roles as therapeutics if inhibition suppresses unwanted reactions. This will be illustrated with examples from our own work. One concerns the use of designed and synthesized mechanism-based inhibitors as potential therapeutics for influenza, through inhibition of the viral neuraminidase1. In a second example I shall show how high-throughput screening of natural product extract libraries has yielded potent inhibitors of human a-amylase that are showing useful potential in control of blood glucose levels in diabetic rats2.

1. Kim, J-H, Resende, R., Wennekes, T., Chen, H., Bance, N., Buchini, S., Watts, A. G., Pilling, P., Streltsov, V. A., Petric, M., Liggins, R., Barrett, S., McKimm-Breschkin, J. L., Niikura, M. and Withers, S. G. “Mechanism-based Covalent Neuraminidase Inhibitors with Broad Spectrum Influenza Antiviral Activity” (2013) Science, 340, 71-75.

2. Tarling, C. A., Woods, K., Brastianos, H. C., Zhang, R., Brayer, G. D., Andersen, R. J. and Withers, S. G. “The Search for Novel Human Pancreatic a-Amylase Inhibitors: High-Throughput Screening of Terrestrial and Marine Natural Product Extracts” (2008) ChemBioChem. 9, 433-438.